It is a healthcare private not for profit company based in Pune, Maharashtra, India, established in 2011.
2011 | Pune, Maharashtra, India | ActiveInstitute For Prostate Cancer, a active private not for profit company, was established on 22 November 2011 in Pune, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85100PN2011NPL141427. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Aarti Mahendra Upadhye (Director), Dattatraya Chintaman Joglekar (Director). Past directors included Ashutosh Kumar Tewari, Babasaheb Neelkanth Kalyani, Amit Babasaheb Kalyani. Its latest AGM occurred on 02 September 2024, with the balance sheet filed on 31 March 2024. It is based at Pune Cantonment Mundhwa, Pune, Maharashtra, 411036.
U85100PN2011NPL141427
141427
22 November 2011
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Institute For Prostate Cancer — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aarti Mahendra Upadhye | Director | 01 Jan 2021 | Current |
| Dattatraya Chintaman Joglekar | Director | 01 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 27 Sep 2012 | Past |
| Pramod Abcsdd | Director | 28 Mar 2015 | Past |
| Pramod Abcsdd | Director | 20 Dec 2017 | Past |
| Pramod Abcsdd | Director | 01 Jan 2021 | Past |
| Pramod Abcsdd | Additional Director | 01 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Institute For Prostate Cancer, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 56.78% increase in profit. The company's net worth dipped by a decrease of 1.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Institute For Prostate Cancer had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Institute For Prostate Cancer, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Institute For Prostate Cancer, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Institute For Prostate Cancer's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Institute For Prostate Cancer last Annual general meeting of members was held on 02 Sep 2024 as per latest MCA records. was documented.
The activity Institute For Prostate Cancer has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
The activity Aarti Mahendra Upadhye was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was completed.
The activity Dattatraya Chintaman Joglekar was appointed as a Director was appointed as a Director on 01 Jan 2021 & has been associated with this company since 4 years 11 months . was completed.
Progress on Institute For Prostate Cancer was registered on 22 Nov 2011 with Roc Pune & aged 14 years 1 month as per MCA records. was documented.
The CIN of Institute For Prostate Cancer is U85100PN2011NPL141427.
Institute For Prostate Cancer is headquartered at Pune Cantonment Mundhwa, Pune, Maharashtra, 411036.
Institute For Prostate Cancer was incorporated on 22 November 2011.
The current directors of Institute For Prostate Cancer are
The primary industry of Institute For Prostate Cancer is Hospital And Medical Care.
Institute For Prostate Cancer is unlisted.
The authorized capital of Institute For Prostate Cancer is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Institute For Prostate Cancer is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX